NanoGroup S.A. (WSE:NNG)

Market Cap	86.20M
Revenue (ttm)	-6.90K
Net Income (ttm)	-6.93M
Shares Out	32.16M
EPS (ttm)	-0.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,677
Average Volume	52,183
Open	2.605
Previous Close	2.650
Day's Range	2.605 - 2.700
52-Week Range	2.250 - 3.830
Beta	0.83
RSI	50.16
Earnings Date	Jan 29, 2026

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.